Digital peroral pancreatoscopy to determine surgery for patients who have intraductal papillary mucinous neoplasms of the pancreas with mural nodules

Abstract

Background and study aims Because more than a few patients have intraductal papillary mucinous neoplasms of the pancreas (IPMNs) with mural nodules (MNs) that are benign, clinical plans should be determined by using histocytological specimens especially, for patients with high risk for surgery or with a small MN.

Patients and methods This study included 27 patients to evaluate the efficacy of peroral pancreatoscopy using a SpyGlass DS system (POPS-DS) for patients with MN-positive IPMN, mainly focusing on the ability of POPS-DS to detect malignancy.

Results Biopsy specimens obtained under POPS-DS guidance could be used for histological evaluation of all patients with MNs in the main pancreatic duct and 67% of the patients with MNs in the branch ducts, whereas fluid specimens collected during POPS-DS could be used for histocytological evaluation for all patients. For the 13 patients who underwent surgery just after POPS-DS, the sensitivity, specificity, and accuracy of POPS-DS to detect malignancy were 89%, 100%, and 92%, respectively. For the 12 patients who underwent surveillance without surgery, the cumulative 3-year progression rates for nine benign IPMNs and three malignant ones determined using POPS-DS were 0% and 100%, respectively. However, the sensitivity of POPS to detect IPMN epithelium in the resection margin was 20%. Only one patient developed procedure-related pancreatitis (mild).

Conclusions POPS-DS could be used to accurately detect malignancy in patients with MN-positive IPMN. Therefore, histocytological evaluation using POPS-DS can contribute to selection of patients for whom surgery would be appropriate.

Keywords

Pancreatobiliary (ERCP/PTCD) - Pancreatoscopy - Endoscopic ultrasonography - Pancreas - Tissue diagnosis

Publikationsverlauf

Eingereicht: 22. Mai 2024

Angenommen nach Revision: 25. Oktober 2024

Accepted Manuscript online:
28. Oktober 2024

Artikel online veröffentlicht:
28. November 2024

• References

• 1 Tanaka M, Fernández-Del Castillo C, Kamisawa T. et al. Revisions of international consensus Fukuoka guidelines for the management of IPMN of the pancreas. Pancreatology 2017; 17: 738-753
• 2 Ohtsuka T, Fernandez-Del Castillo C, Furukawa T. et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology 2024; 24: 255-270
• 3 Shimizu Y, Hijioka S, Hirono S. et al. New model for predicting malignancy in patients with intraductal papillary mucinous neoplasm. Ann Surg 2020; 272: 155-162
• 4 Kim TH, Song TJ, Hwang JH. et al. Predictors of malignancy in pure branch duct type intraductal papillary mucinous neoplasm of the pancreas: A nationwide multicenter study. Pancreatology 2015; 15: 405-410
• 5 Kobayashi G, Fujita N, Maguchi H. et al. Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan Pancreas Society multicenter study. Pancreas 2014; 43: 532-538
• 6 Masaki Y, Koshita S, Noda Y. et al. Should we regard all main duct type intraductal papillary mucinous neoplasms of the pancreas (MD-IPMN as an indication of surgery? -A retrospective study in 29 patients with MD-IPMN showing mural nodules. Pancreatology 2019; 19: 352-359
• 7 Hara T, Yamaguchi T, Ishihara T. et al. Diagnosis and patient management of intraductal papillary-mucinous tumor of the pancreas by using peroral pancreatoscopy and intraductal ultrasonography. Gastroenterology 2002; 122: 34-43
• 8 Yamaguchi T, Shirai Y, Ishihara T. et al. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy. Cancer 2005; 104: 2830-2836
• 9 Nagayoshi Y, Aso T, Ohtsuka T. et al. Peroral pancreatoscopy using the SpyGlass system for the assessment of intraductal papillary mucinous neoplasm of the pancreas. J Hepatobiliary Pancreat Sci 2014; 21: 410-417
• 10 Arnelo U, Siiki A, Swahn F. et al. Single-operator pancreatoscopy is helpful in the evaluation of suspected intraductal papillary mucinous neoplasms (IPMN. Pancreatology 2014; 14: 510-514
• 11 Trindade AJ, Benias PC, Kurupathi P. et al. Digital pancreatoscopy in the evaluation of main duct intraductal papillary mucinous neoplasm: a multicenter study. Endoscopy 2018; 50: 1095-1098
• 12 de Jong DM, Stassen PMC, Groot Koerkamp B. et al. The role of pancreatoscopy in the diagnostic work-up of intraductal papillary mucinous neoplasms: a systematic review and meta-analysis. Endoscopy 2023; 55: 25-35
• 13 Koshita S, Noda Y, Ito K. et al. Pancreatic juice cytology with immunohistochemistry to detect malignancy and histologic subtypes in patients with branch duct type intraductal papillary mucinous neoplasms of the pancreas. Gastrointest Endosc 2017; 85: 1036-1046
• 14 Noda Y, Fujita N, Kobayashi G. et al. Prospective randomized controlled study comparing cell block method and conventional smear method for pancreatic juice cytology. Dig Endosc 2012; 24: 168-174
• 15 Koshita S, Noda Y, Kanno Y. et al. Value of repeated cytology for intraductal papillary mucinous neoplasms of the pancreas with high-risk potential of malignancy: Is it a promising method for monitoring a malignant transformation?. Pancreatology 2020; 20: 1164-1174
• 16 Leonhardt CS, Hinz U, Kaiser J. et al. Presence of low-grade IPMN at the pancreatic transection margin does not have prognostic significance after resection of IPMN-associated pancreatic adenocarcinoma. Eur J Surg Oncol 2023; 49: 113-121
• 17 Yang D, Trindade AJ, Yachimski P. et al. histologic analysis of endoscopic ultrasound-guided through the needle microforceps biopsies accurately identifies mucinous pancreas cysts. Clin Gastroenterol Hepatol 2019; 17: 1587-1596
• 18 Kitano M, Yoshida M, Ashida R. et al. Needle tract seeding after endoscopic ultrasound-guided tissue acquisition of pancreatic tumors: A nationwide survey in Japan. Dig Endosc 2022;